Showing results (361-370 of 375) with videos related to

Sort By:
Pageof 38
Psychiatry Research|July 15, 2014
Association between dopa decarboxylase gene variants and borderline personality disorderArian Mobascher, Martin Bohus, Norbert Dahmen, et al.
Phytotherapy Research : PTR|November 24, 2017
Citrus essential oils inhalation by mice: Behavioral testing, GCMS plasma analysis, corticosterone, and melatonin levels evaluationAdriana Nunes Wolffenbüttel, Amanda Zamboni, Gabriela Becker, et al.
Neuron|March 18, 2025
A transcriptional atlas of gut-innervating neurons reveals activation of interferon signaling and ferroptosis during intestinal inflammationPatrycja M Forster, Manuel O Jakob, Dilmurat Yusuf, et al.
Network Neuroscience (Cambridge, Mass.)|October 27, 2025
Stable brain PET metabolic networks using a multiple sampling schemeGuilherme Schu, Christian Limberger, Wagner S Brum, et al.
Molecular Cancer|March 31, 2022
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasisTanja Limberger, Michaela Schlederer, Karolina Trachtová, et al.
Molecular Psychiatry|September 4, 2025
Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic reviewLuiza S Machado, Pedro Vidor, Lavínia Perquim, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 12, 2026
Coordinated IFN-γ/TNF Axis Drives Selective Loss of Activated Enteric Glia in Inflammatory Bowel DiseasesMarvin Bubeck, Klara A Penkert, Heidi Limberger, et al.
Bioactive Materials|April 7, 2022
Antibiofilm and immunomodulatory resorbable nanofibrous filing for dental pulp regenerative proceduresMauricio Gonçalves da Costa Sousa, Gabriela Conceição de Almeida, Danilo César Martins Mota, et al.
Molecular Systems Biology|April 24, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancerMonika Oberhuber, Matteo Pecoraro, Mate Rusz, et al.
Molecular Cancer|November 1, 2024
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Pageof 38